Description
A specialized pro-resolving mediator; increases macrophage numbers and phagocytic activity and decreases the resolution phase by 57% in an acute microbial-induced peritonitis model of inflammation in mice; reduces the levels of PGE2, PGD2, and TXB2 in peritoneal exudates,
Formal name: (4Z,7Z,10Z,12E,14E,16R,17S,19Z)-16-(((R)-2-((S)-4-amino-4-carboxybutanamido)-3-((carboxymethyl)amino)-3-oxopropyl)thio)-17-hydroxydocosa-4,7,10,12,14,19-hexaenoic acid
Synonyms: Protein Conjugates in Tissue Regeneration 1
Molecular weight: 649.8
CAS: 1810710-59-8
Purity: ≥96%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Docosanoids||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Specialized Pro-Resolving Mediators||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease||Research Area|Lipid Biochemistry|Lipoxygenase Pathways